Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study

OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect on type 1 diabetes risk. RESEARCH DESIGN AND METHODS: Children were up to 10...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Vehik, Kendra, Lynch, Kristian F., Schatz, Desmond A., Akolkar, Beena, Hagopian, William, Rewers, Marian, She, Jin-Xiong, Simell, Olli, Toppari, Jorma, Ziegler, Anette-G., Lernmark, Åke, Bonifacio, Ezio, Krischer, Jeffrey P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2016
Témata:
Epidemiology/Health Services Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001144/
https://ncbi.nlm.nih.gov/pubmed/27311490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0181
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky